All Q1 FY27 results →
MO

Meghmani Organics Ltd

Q1 FY27Fertilizers & Agrochemicals

Meghmani Organics Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹62
Market cap₹1.6K Cr
P/E25.0
Updated25 Aug 2026
Read4 min read

What the Q1 FY27 call signalled

0 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexNo capex planned

The short version

Crop Protection Segment: - Optimistic outlook for next 2-3 years with double-digit top-line growth. Meghmani Organics is optimistic about long-term growth, particularly in Crop Protection and Crop Nutrition segments, expecting healthy top-line and bottom-line growth over the next 2-3 years.

From Meghmani Organics Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Moderate growth
  • Crop Protection Segment:
  • Optimistic outlook for next 2-3 years with double-digit top-line growth.
  • Volume decline of ~17% in the recent quarter due to macro factors but expected to recover.
  • Focus on profitability alongside revenue growth; aiming for industry-average EBITDA margin of 15-17%.
  • Healthy growth expected in both revenue and volumes over the medium term.
  • Pigment Segment:
  • Revenue expected to remain stable around INR 500-600 crores annually.
  • Capacity utilization likely to stay around 40-50%.
  • EBITDA margin targeted near 10%, maintaining better profitability rather than pushing volume.
  • No significant revenue growth planned due to market overcapacity and muted demand.
  • Crop Nutrition (Nano Fertilizers):
  • Positive contribution currently with optimistic long-term growth.
  • Expansion of product basket (Nano Urea, Nano DAP, Nano NPK, Nano Zinc).

2 more points from Meghmani Organics Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Meghmani Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

No capex planned
  • Meghmani Organics Limited does not plan to do heavy capex for the next one to two years. (Page 14)
  • Growth focus will be driven by investments in new registrations and product developments, especially in the Crop Protection and Crop Nutrition segments. (Pages 5, 6)
  • The company is expanding its Nano fertilizer product basket with new products like Nano DAP, Nano NPK, and Nano Zinc, indicating ongoing investment in product development. (Pages 3, 11)

2 more points from Meghmani Organics Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Meghmani Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The following related points are noted: - The company experienced softer demand across key markets resulting in subdued off-take during the quarter. - Healthy demand is seen in both Crop Protection and Pigment segments, with customers buying on a spot basis rather than building inventory. - For the Crop Nutrition segment, expansion of the product basket with new nano fertilizers has resulted in trial orders in different markets, showing encouraging results.

2 more points from Meghmani Organics Ltd's call on order book

Create a free account to keep reading this call

Meghmani Organics Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹474 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Rama Phosphates (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹22,480 Lacs, up 18% YoY from ₹19,031 Lacs in Q1 FY26. Key investor presentation takeaways from Rama Phosphates's Q1 FY27 inves

  • Advance Agrolife (Q1 FY27)

    Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…

  • Bhagiradha Chem. (Q1 FY27)

    195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Sumitomo Chemi. (Q1 FY27)

    1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY27 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Meghmani Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Meghmani Organics Ltd Q1 FY27 results?

Crop Protection Segment: - Optimistic outlook for next 2-3 years with double-digit top-line growth. Meghmani Organics is optimistic about long-term growth, particularly in Crop Protection and Crop Nutrition segments, expecting healthy top-line and bottom-line growth over the next 2-3 years.

What is Meghmani Organics Ltd share price analysis?

Meghmani Organics Ltd currently shows a below-average growth signal. The stock trades at a P/E of 25.0 with a market cap of ₹1,608 Cr. Investors should review the full earnings analysis for detailed insights.

Is Meghmani Organics Ltd planning capital expenditure?

Meghmani Organics Limited does not plan to do heavy capex for the next one to two years.

Keep Meghmani Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.